MVM Partners has closed its sixth healthcare fund, MVM VI, with $500m in limited partner commitments. Demand was well above the hard cap. MVM has been investing in high growth healthcare businesses since 1997.
MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
MVM invests in both private and public companies. Typical projected investment in each company is $30 to $60 million, but with capacity for larger investments.
MVM has been investing in high growth healthcare businesses since 1997. MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health. MVM invests in both private and public companies.
Source: Private Equity Wire
Can’t stop reading? Read more
LGT Capital Partners takes minority stake in CVC-backed Teneo at $2.3bn valuation
LGT Capital Partners takes minority stake in CVC-backed Teneo at $2.3bn valuation LGT Capital...
BlueFive Capital lands sovereign backing from Bahrain’s Mumtalakat
BlueFive Capital lands sovereign backing from Bahrain’s Mumtalakat Bahrain’s sovereign wealth...
Green Arrow Capital to acquire De Agostini’s alternatives arm in portfolio reshuffle
Green Arrow Capital to acquire De Agostini’s alternatives arm in portfolio reshuffle Green Arrow...